Bill Text

Bill Information


Bill PDF |Add To My Favorites |Track Bill | print page

AB-2680 Alzheimer’s disease.(2023-2024)

SHARE THIS: share this bill in Facebook share this bill in Twitter
Date Published: 09/23/2024 02:00 PM
AB2680:v95#DOCUMENT

Assembly Bill No. 2680
CHAPTER 335

An act to amend Section 1568.17 of the Health and Safety Code, relating to Alzheimer’s disease.

[ Approved by Governor  September 21, 2024. Filed with Secretary of State  September 21, 2024. ]

LEGISLATIVE COUNSEL'S DIGEST


AB 2680, Aguiar-Curry. Alzheimer’s disease.
Existing law requires the Secretary of California Health and Human Services to be responsible for oversight and coordination of programs serving people living with Alzheimer’s disease and related conditions, and their families. Existing law establishes the Alzheimer’s Disease and Related Disorders Advisory Committee in the California Health and Human Services agency, and specifies the committee’s duties, including requirements for making policy and plan recommendations.
This bill would rename the advisory committee to the Alzheimer’s Disease and Related Conditions Advisory Committee, and expand the number of members serving on the committee from 14 to at least 16, but not more than 20, members. The bill would prescribe the qualifications of certain members on the committee, and revise the duties of the committee. The bill would, in the provisions governing the committee, revise references to Alzheimer’s disease to also refer to related conditions.
This bill would incorporate additional changes to Section 1568.17 of the Health and Safety Code proposed by AB 2207 to be operative only if this bill and AB 2207 are enacted and this bill is enacted last.
Vote: MAJORITY   Appropriation: NO   Fiscal Committee: YES   Local Program: NO  

The people of the State of California do enact as follows:


SECTION 1.

 Section 1568.17 of the Health and Safety Code is amended to read:

1568.17.
 (a) The California Health and Human Services Agency shall establish an Alzheimer’s Disease and Related Conditions Advisory Committee representing the diversity of California and that consists of at least 16, but not more than 20, members, which shall include, but not be limited to, all of the following:
(1) One representing the field of academic medical research.
(2) One representing the field of social research.
(3) One representing the field of behavioral health.
(4) One representing organizations providing adult day care services focused on persons living with Alzheimer’s disease or related conditions.
(5) One representing the California Alzheimer’s Disease Centers.
(6) Two representing families of persons directly affected by Alzheimer’s disease or related conditions.
(7) Two representing organizations providing services to persons living with Alzheimer’s disease or related conditions.
(8) One representing a consumer organization representing persons with Alzheimer’s disease or related conditions.
(9) One representing a member of the State Bar who is familiar with the legal issues confronting those living with Alzheimer’s disease or related conditions and their families.
(10) Two people who have been diagnosed with Alzheimer’s disease or a related condition.
(11) The Secretary of California Health and Human Services or their designee.
(12) Two ex officio, nonvoting members, consisting of one Senator appointed by the Senate Committee on Rules and one Member of the Assembly appointed by the Speaker of the Assembly. These members shall participate in the activities of the committee to the extent that their participation is not incompatible with their respective positions as Members of the Legislature.
(13) Up to four additional members selected by the Secretary of California Health and Human Services.
(b) Members described in paragraphs (1) to (10), inclusive, and paragraph (13), of subdivision (a) shall serve at the pleasure of the Secretary of California Health and Human Services. Members described in paragraph (12) of subdivision (a) shall serve at the pleasure of their appointing authority. The agency secretary may establish fixed terms for advisory committee membership. For purposes of continuity, those terms shall be staggered.
(c) Members shall serve without compensation, but shall receive reimbursement for travel and other necessary expenses actually incurred in the performance of their official duties.
(d) The Alzheimer’s Disease and Related Conditions Advisory Committee shall do all of the following:
(1) Provide ongoing advice and assistance to the administration and the Legislature as to the program needs and priorities of the target population.
(2) Provide planning support to the administration and the Legislature by tracking, monitoring, and considering recommendations made in the final report of the Governor’s Task Force on Alzheimer’s (Disease) Prevention and Preparedness, and the California Master Plan for Aging, in addition to other state plans and reports, including the California State Plan for Alzheimer’s Disease, as needed.
(3) Appoint a chairperson and vice chairperson.
(4) Meet quarterly.
(e) The Alzheimer’s Disease and Related Conditions Advisory Committee shall do all of the following when making policy and plan recommendations:
(1) Consult with a broad range of stakeholders, including, but not limited to, people diagnosed with Alzheimer’s disease or related conditions, family members or informal caregivers, community-based and institutional providers, Alzheimer’s disease or related conditions researchers and academicians, direct care workforce, the Alzheimer’s Association, the California Commission on Aging, and other state entities.
(2) Consider cultural and linguistic factors that impact persons with Alzheimer’s disease or related conditions and their families who are from diverse communities.
(3) Review current state policies and practices concerning care and treatment related to Alzheimer’s disease and other related conditions, as well as risk reduction, and develop recommendations concerning all of the following issues:
(A) Community-based support for California’s racially, ethnically, culturally, and linguistically diverse people living with Alzheimer’s disease or related conditions and their family members or informal caregivers.
(B) Choices for care and residence for persons with Alzheimer’s disease or related conditions and their families.
(C) An integrated public health care management approach to Alzheimer’s disease or related conditions in health care settings that makes full use of dementia care practices.
(D) The dementia training and competence of health care professionals.
(E) Risk reduction, early identification, and intervention through increasing public awareness of Alzheimer’s disease and related conditions, as well as brain health.
(f) All meetings of the advisory committee, and any subcommittees thereof, shall be open to the public and adequate notice shall be provided in accordance with Article 9 (commencing with Section 11120) of Chapter 1 of Part 1 of Division 3 of Title 2 of the Government Code.

SEC. 1.5.

 Section 1568.17 of the Health and Safety Code is amended to read:

1568.17.
 (a) The California Health and Human Services Agency shall establish an Alzheimer’s Disease and Related Conditions Advisory Committee representing the diversity of California and that consists of at least 17, but not more than 21, members, which shall include, but not be limited to, all of the following:
(1) One representing the field of academic medical research.
(2) One representing the field of social research.
(3) One representing the field of behavioral health.
(4) One representing organizations providing adult day care services focused on persons living with Alzheimer’s disease or related conditions.
(5) One representing the California Alzheimer’s Disease Centers.
(6) Two representing families of persons directly affected by Alzheimer’s disease or related conditions.
(7) Two representing organizations providing services to persons living with Alzheimer’s disease or related conditions.
(8) One representing a consumer organization representing persons with Alzheimer’s disease or related conditions.
(9) One representing a member of the State Bar who is familiar with the legal issues confronting those living with Alzheimer’s disease or related conditions and their families.
(10) Two people who have been diagnosed with Alzheimer’s disease or a related condition.
(11) The Executive Director of the California Commission on Aging or the director’s designee.
(12) The Secretary of California Health and Human Services or their designee.
(13) Two ex officio, nonvoting members, consisting of one Senator appointed by the Senate Committee on Rules and one Member of the Assembly appointed by the Speaker of the Assembly. These members shall participate in the activities of the committee to the extent that their participation is not incompatible with their respective positions as Members of the Legislature.
(14) Up to four additional members selected by the Secretary of California Health and Human Services.
(b) Members described in paragraphs (1) to (11), inclusive, and paragraph (14), of subdivision (a) shall serve at the pleasure of the Secretary of California Health and Human Services. Members described in paragraph (13) of subdivision (a) shall serve at the pleasure of their appointing authority. The agency secretary may establish fixed terms for advisory committee membership. For purposes of continuity, those terms shall be staggered.
(c) Members shall serve without compensation, but shall receive reimbursement for travel and other necessary expenses actually incurred in the performance of their official duties.
(d) The Alzheimer’s Disease and Related Conditions Advisory Committee shall do all of the following:
(1) Provide ongoing advice and assistance to the administration and the Legislature as to the program needs and priorities of the target population.
(2) Provide planning support to the administration and the Legislature by tracking, monitoring, and considering recommendations made in the final report of the Governor’s Task Force on Alzheimer’s (Disease) Prevention and Preparedness, and the California Master Plan for Aging, in addition to other state plans and reports, including the California State Plan for Alzheimer’s Disease, as needed.
(3) Appoint a chairperson and vice chairperson.
(4) Meet quarterly.
(e) The Alzheimer’s Disease and Related Conditions Advisory Committee shall do all of the following when making policy and plan recommendations:
(1) Consult with a broad range of stakeholders, including, but not limited to, people diagnosed with Alzheimer’s disease or related conditions, family members or informal caregivers, community-based and institutional providers, Alzheimer’s disease or related conditions researchers and academicians, direct care workforce, the Alzheimer’s Association, the California Commission on Aging, and other state entities.
(2) Consider cultural and linguistic factors that impact persons with Alzheimer’s disease or related conditions and their families who are from diverse communities.
(3) Review current state policies and practices concerning care and treatment related to Alzheimer’s disease and other related conditions, as well as risk reduction, and develop recommendations concerning all of the following issues:
(A) Community-based support for California’s racially, ethnically, culturally, and linguistically diverse people living with Alzheimer’s disease or related conditions and their family members or informal caregivers.
(B) Choices for care and residence for persons with Alzheimer’s disease or related conditions and their families.
(C) An integrated public health care management approach to Alzheimer’s disease or related conditions in health care settings that makes full use of dementia care practices.
(D) The dementia training and competence of health care professionals.
(E) Risk reduction, early identification, and intervention through increasing public awareness of Alzheimer’s disease and related conditions, as well as brain health.
(f)  All meetings of the advisory committee, and any subcommittees thereof, shall be open to the public and adequate notice shall be provided in accordance with Article 9 (commencing with Section 11120) of Chapter 1 of Part 1 of Division 3 of Title 2 of the Government Code.

SEC. 2.

 Section 1.5 of this bill incorporates amendments to Section 1568.17 of the Health and Safety Code proposed by both this bill and Assembly Bill 2207. That section of this bill shall only become operative if (1) both bills are enacted and become effective on or before January 1, 2025, (2) each bill amends Section 1568.17 of the Health and Safety Code, and (3) this bill is enacted after Assembly Bill 2207, in which case Section 1 of this bill shall not become operative.